The tumor suppressor gene p53 is a paradigm for multi-functional regulator of processes ranging from proliferation to replicative senescence and apoptosis. P53 is the most commonly afflicted gene in human cancers, and its loss of function can be an early or late event in the malignant process. Thus, detailed investigators of its normal effector pathways and their interactions as well as mechanisms affecting p53 regulation are critical to understand of the role of p53 loss in cancer as well as efforts to intervene in this process. The four projects in this Program focus on the cellular responses to p53 which have been implicated in growth arrest, apoptosis, or senescence. This program brings together a unique group of investigators representing a variety of disciplines and approaches ranging from studies on protein stability to developmental biology. Many have recently come to Mount Sinai as part of a major initiative to expand the cancer research enterprise at this Institution. Four of the six Investigators (Aaronson, Ronai, Licht and Sassoon) have recently become actively involved in studies relative to p53. Thus they bring new perspectives to this field which has already led to new hypotheses and a broader understanding of p53 pathways. Thus they bring new perspectives to this field which has already led to new hypotheses and a broader understanding of p53 pathways. Accordingly, this unique combination of perspectives will focus on the elucidation of a new understanding of mechanisms underlying the ability of p53 to exercise its multiple functions. The specific problems addressed are: how p53 regulates cellular senescence (Project 1); identifying mechanisms underlying the regulation of p53 stability (Project 2); elucidating convergent roles of BRCA1 and p53 in gene expression (Project 3); and the mechanisms by which a p53-regulated genes, P21 and Siah1, dictate cell survival and death pathways (Project 4). Our proposal contains collaborations utilizing shared reagents and resources which enable us to address endpoints that would not be reached by any single project.. The proposed work will benefit from a core facility, knockout cell culture, which will enable us to make rapid progress on each of our collective Aims. This critical mass was formed to address a focused set of innovative hypotheses, which will provide new understanding of mechanisms concerning the multiple functions exerted by the tumor suppressor p53.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA080058-01A1
Application #
6027842
Study Section
Subcommittee G - Education (NCI)
Program Officer
Blair, Donald G
Project Start
2000-02-16
Project End
2005-01-31
Budget Start
2000-02-16
Budget End
2001-01-31
Support Year
1
Fiscal Year
2000
Total Cost
$1,189,894
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Pappas, Kyrie; Xu, Jia; Zairis, Sakellarios et al. (2017) p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes. Mol Cancer Res 15:1051-1062
Mungamuri, Sathish Kumar; Qiao, Rui F; Yao, Shen et al. (2016) USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation. Cell Rep 14:2528-37
Muñoz-Fontela, César; Mandinova, Anna; Aaronson, Stuart A et al. (2016) Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nat Rev Immunol 16:741-750
Ou, Yang; Wang, Shang-Jui; Li, Dawei et al. (2016) Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci U S A 113:E6806-E6812
Guernet, Alexis; Mungamuri, Sathish Kumar; Cartier, Dorthe et al. (2016) CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations. Mol Cell 63:526-38
Meslamani, Jamel; Smith, Steven G; Sanchez, Roberto et al. (2016) Structural features and inhibitors of bromodomains. Drug Discov Today Technol 19:3-15
Hwang, So-Young; Deng, Xianming; Byun, Sanguine et al. (2016) Direct Targeting of ?-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/?-Catenin Signaling. Cell Rep 16:28-36
Shi, D; Dai, C; Qin, J et al. (2016) Negative regulation of the p300-p53 interplay by DDX24. Oncogene 35:528-36
Tavana, Omid; Li, Dawei; Dai, Chao et al. (2016) HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nat Med 22:1180-1186
Wang, Donglai; Kon, Ning; Lasso, Gorka et al. (2016) Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode. Nature 538:118-122

Showing the most recent 10 out of 101 publications